- CA$626.51m
- CA$601.75m
- CA$63.26m
Brief: Kneat Announces Record Saas Revenue For Fourth Quarter And Full Year 2022
Brief: Kneat Announces Saas Revenue In Q3 2022
Brief: Kneat Announces Record Saas Revenue In Q2 2022
Brief: European National Health Service Selects Kneat's Evalidation Platform
Brief: Canadian Generics Pharmaceutical Manufacturer Selects Kneat's Saas E-Validation Platform
Brief: Kneat Announces Q4 And Full Year 2021 Results
Brief: Kneat Announces Changes To Board Of Directors
Brief: Leading Consumer Packaged Goods Company Selects Kneat's Saas Platform
Brief: Kneat Achieves Posts Q3 Revenue Of $3.7 Million
Brief: Kneat Announces Conditional Approval To List On The Toronto Stock Exchange
Brief: Kneat Says Qtrly Total Revenues Increased 104%
Brief: Kneat Announces $17.5 Million Bought Deal Public Offering
Brief: Kneat Reports First Quarter Results
Brief: Kneat Reports Q4 Revenue Of $1.40 Mln
Brief: Kneat.Com - Signed 5-Year Master Service Agreement With A Biopharmaceutical Co
Brief: Kneat Says Hugh Kavanagh Appointed CFO
Brief: Big Pharma Selects Kneat's Commissioning, Qualification, Validation Platform
Brief: Kneat Reports Q2 Net Loss Of $1.8 Million
Brief: Kneat Reports First Quarter Results